Sports nutrition is witnessing rapid growth with a focus on discovering the link between nutrition & performance, ignoring nutrition’s role in EIMD.
High-force eccentric muscle action makes ultrastructural muscular disarrangements in Z-line streaming causing delayed onset of muscle soreness (DOMS), increased circulation of specific intramuscular proteins, swelling, less movement, hampered muscle force capacity & decreased pressure pain threshold immediately & for up to 14 days after the 1st exercise spurt.
The intensity depends upon exercise damage duration & individual’s vulnerability towards a damaging stimulus.
Exercise forms resulting in EIMD comprise resistance training, prolonged running, downhill running & intermittent and high-intensity exercise.
Primary damage – happens due to mechanical work conducted post-contractile & non-contractile disruption initiated by eccentric contraction.
Secondary damage- additional damage is created by an unlimited number of Ca2+ moving inside the cytoplasm. This triggers Ca2+-dependent proteolytic & phospholipase A2 pathways causing protein structure damage. Subsequently, there is Ca2+ overload & permeabilization in the inner mitochondrial membrane and extensive efflux of Ca2+ from the mitochondria, with more intracellular Ca2+ concentration causing apoptosis. There is unmanageable muscle contraction, neutrophil infiltration, proteolysis & proinflammatory cytokine release.
Satellite cells get activated, and muscle regains the potential capacity to organize an increased response to a frequent myofiber homeostasis challenge.
DOMS is the most commonly assessed marker which appears between 8 - 24 h after muscle-damaging exercise, peaks between 24 - 48 h & sinks within 96 h.
2-6 days after initial damage, Cytokinine in plasma and myoglobin in serum appearance peaks.
Skilfully designed nutritional interventions are required to support the recovery process.
Important for muscle protein turnover, adaptive processes, reducing muscle damage markers & enhancing recovery during exercise.
Functional foods –
• Dietary polyphenols-
Quercetin, Catechins & ellagitannins obtained from fruits & vegetables support recovery, provide antioxidant & anti-inflammatory benefits, and weaken arachidonic acid pathways.
• Omega 3 PUFA- n-3 PUFA
Eicosapentaenoic acid (EPA) & docosahexaenoic acid (DHA) from nuts & oily fish give anti-inflammatory advantages.
Vitamin D –
An adequate dose is pivotal for the damaged muscle’s intrinsic repair at the cellular level.
Vitamin C & E-
May scavenge free radicals, and prevent cell damage & inflammation.
Furnish optimistic effects on satellite cell numbers & myonuclear content post exercise & influence skeletal myoblasts myotube formation.
Practical cautious nutritional solutions to modulate EIMD
1. Expand recovery, increase training stimulus, boost adaptive response & reduce performance injuries during EIMD
2. Include a balanced diet enriched with fruits & vegetables
3. Add nutritional supplements under the trainer’s & healthcare professionals’ supervision
EIMD has a complex aetiology comprising difficult contributing factors that sometimes may amplify or resolve muscle damage. Sensible nutritional regimens can establish a delicate periodised steady approach during EIMD.
1.
Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma
2.
According to new studies, some cancer patients can safely forego radiation therapy.
3.
According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.
4.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
5.
Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk
1.
Unlocking the Secrets of Hemoglobin: How It Works to Keep Us Healthy
2.
Studying Lactic Acid in Pediatric Tumor Microenvironments: Experimental Approaches Explored
3.
Community-Based Cancer Survivorship Support Systems
4.
Omitting Axillary Dissection in Node-Positive Breast Cancer: Insights from the SENOMAC Trial
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
3.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
4.
Navigating the Complexities of Ph Negative ALL - Part III
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation